To hear about similar clinical trials, please enter your email below
Trial Title:
Mindfulness-Based Ecological Momentary Intervention For Smoking Cessation Among Cancer Survivors
NCT ID:
NCT06476548
Condition:
Any Cancer Type
Conditions: Keywords:
Smoking Cessation
Cancer Survivor
Study type:
Interventional
Study phase:
N/A
Overall status:
Active, not recruiting
Study design:
Allocation:
N/A
Intervention model:
Single Group Assignment
Primary purpose:
Prevention
Masking:
None (Open Label)
Intervention:
Intervention type:
Behavioral
Intervention name:
EMI
Description:
Participants will complete 3 counseling sessions (30 minutes), download and use a
smartphone app for 4 weeks, complete 2 online surveys, and a brief phone call at the end
of the study to provide feedback. In the first 3 weeks, participants will use the
prototype app every day to complete ecological momentary assessments (EMAs), receive
brief mindful skills, and practice formal mindfulness meditations (5-20 minutes). In the
final week, participants will continue completing EMAs. Participants will also be
provided with nicotine patches.
Arm group label:
Usability Testing
Summary:
The purpose of the study is to obtain feedback on a new quit-smoking treatment among
individuals with a cancer diagnosis using a prototype app we developed.
Detailed description:
The study aims to test the usability of the prototype app in conjunction with
face-to-face brief cessation counseling and nicotine replacement therapy in a single-arm
trial.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Having smoked at least one cigarette (even one or two puffs) within the past 30
days.
- Having been diagnosed with cancer.
- Willing to give quitting a try as part of the study.
- Having a smartphone that allows installation of the app.
- Willingness to download and use the app daily.
- Valid home address and functioning phone number.
- Being able to read, write, and speak English.
Exclusion Criteria:
- Being enrolled in a smoking cessation program.
- Current use of smoking cessation medications.
- Evidence of current psychosis.
- Current/planning pregnancy or lactation.
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Moffitt Cancer Center
Address:
City:
Tampa
Zip:
33612
Country:
United States
Start date:
June 21, 2023
Completion date:
June 2026
Lead sponsor:
Agency:
H. Lee Moffitt Cancer Center and Research Institute
Agency class:
Other
Collaborator:
Agency:
National Cancer Institute (NCI)
Agency class:
NIH
Source:
H. Lee Moffitt Cancer Center and Research Institute
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06476548
https://www.moffitt.org/clinical-trials-research/clinical-trials/
